Meikang Biotech (300439.SZ) plans to launch the 2026 Restricted Stock Incentive Plan

According to the Zhitong Finance App, Meikang Biotech (300439.SZ) released the 2026 Restricted Stock Incentive Plan (draft). The number of restricted shares to be awarded is 4.23 million shares, accounting for about 1.10% of the company's total share capital on the day the draft incentive plan was announced. Of these, 3.39 million restricted shares were granted for the first time, and 840,000 shares were reserved. The grant price for the initial grant of restricted shares was 4.63 yuan/share.

The incentive plan is valid for a maximum period of no more than 60 months from the date the restricted shares are granted to the incentive target until all restricted shares granted by the incentive target are vested or annulled.